If you've been diagnosed with seminoma, a common form of testicular cancer, it's very likely you'll make a full recovery. This type of cancer, which originates in germ cells in the testicles (also called pure, or classical, seminoma) usually responds well to radiation therapy. Coupled with surgery and chemotherapy, this has helped make survival rates for patients with Stages I and II seminoma nearly 100%.
Part of that success is derived from Yale Medicine’s commitment to advancing the field, says James Yu, MD, MHS, director of Yale Medicine's Prostate & Genitourinary Radiotherapy Program. “We're always looking for even the smallest improvements.”